Overview 

Triploidy is a chromosomal abnormality in which a conceptus has three complete sets of chromosomes (69 chromosomes) instead of the normal diploid complement (46 chromosomes).¹ Triploid conceptuses usually arise from abnormal fertilisation events and are generally non-viable; most are lost in the first trimester. Although the primary consequences of triploidy are fetal, severe malformation, growth restriction, or intrauterine death, the abnormal placentation that often accompanies certain forms of triploidy can cause significant and sometimes life-threatening maternal complications during pregnancy. 

This article summarises the genetic, diagnostic, and clinical picture of triplody, highlights the principal maternal risks (with known mechanisms), and outlines management and counselling considerations for obstetric care. 

Genetics and types of triploidy 

Triploidy is a rare chromosomal condition in which a developing baby has three complete sets of chromosomes, giving a total of 69 instead of the normal 46. The extra set may come from either the father or the mother, and this parental origin plays a crucial role in determining the development of the placenta and the risks posed to the pregnancy.

When the additional set is paternal in origin, the condition is called diandric triploidy.¹ This usually occurs when two sperm fertilise the same egg, though it can also result from duplication of the father’s chromosomes inside the egg.² Pregnancies with diandric triploidy are characterised by an abnormally large placenta, often with features resembling a partial molar pregnancy, where the placental tissue develops in a cyst-like, irregular way. Although the fetus may grow for a time, it is usually affected by significant abnormalities.

In contrast, when the extra set comes from the mother, the condition is referred to as digynic triploidy. This typically happens when the egg fails to divide its chromosomes properly before fertilisation.² A small, underdeveloped placenta marks these pregnancies, and the fetus usually shows severe growth restriction, appearing much smaller than expected for the stage of pregnancy.

Therefore, the parental origin of the extra chromosome set is not just a technical detail: it directly influences the appearance of the placenta, the development of the fetus, and the degree of risk to the mother.

How triploidy is diagnosed 

Triploidy is often suspected during the first trimester. Ultrasound scans may reveal unusual findings, such as abnormal fetal measurements, multiple structural anomalies, or a placenta that is unusually large or cystic in appearance.³ Non-invasive prenatal testing (NIPT), particularly SNP-based methods, can also raise suspicion by detecting signs of an additional chromosome set.⁴

A definitive diagnosis, however, requires cytogenetic testing. This can be done through chorionic villus sampling, amniocentesis, or laboratory analysis of pregnancy tissue after miscarriage or termination.⁵ In some cases, triploidy may be mosaic, meaning only some cells are affected, or confined to the placenta alone. These variations can make diagnosis and counselling more complex, as the outcomes and risks may differ.

Why maternal complications occur

The placenta is central to the complications seen in triploid pregnancies, particularly those of diandric origin. In these cases, the placental tissue often shows trophoblastic hyperplasia (overgrowth) and hydropic villous changes (swelling of placental structures), which are the hallmarks of partial molar changes.⁶ These abnormalities lead the placenta to produce excessive hormones and substances that disrupt the mother’s circulation.

The result is an imbalance of angiogenic factors that regulate blood vessel growth, damage to the lining of maternal blood vessels, and widespread inflammatory responses. Clinically, this can manifest as serious conditions such as early-onset preeclampsia, eclampsia, or, in rare cases, mirror (Ballantyne) syndrome, in which the mother develops swelling and symptoms that mimic those of the unwell fetus.⁷ These risks explain why pregnancies affected by triploidy, particularly of paternal origin, can be dangerous not only for the fetus but also for the mother.

Main maternal risks and clinical features 

Early-onset preeclampsia and hypertensive disorders 

One of the clearest associations is between diandric triploidy/partial molar changes and early-onset preeclampsia (often before 20 weeks). Reviews and case series report a markedly increased risk of severe hypertensive disease in such pregnancies; pooled data indicate a substantial proportion of second-trimester triploid pregnancies develop hypertension/preeclampsia.⁸ The pathophysiology likely reflects abnormal placental release of anti-angiogenic factors (e.g., sFlt-1) and trophoblastic overactivity.

Gestational trophoblastic disease (GTD) and persistent trophoblastic disease 

Some triploid conceptuses (particularly those with partial molar features) can leave residual trophoblast that behaves abnormally; although the malignant potential of partial moles is lower than complete moles, follow-up measurement of β-hCG after evacuation is recommended to exclude persistent GTD and to manage appropriately if levels plateau or rise.⁶

Severe maternal edema / Mirror syndrome (Ballantyne syndrome)

Mirror syndrome describes maternal oedema, hypertension and sometimes preeclampsia-like features that "mirror" fetal hydrops. It has been reported in pregnancies where the fetus has hydrops or a massively abnormal placenta (including triploid placentas with molar changes).⁷ The syndrome may progress rapidly and require prompt intervention.

Antepartum and postpartum haemorrhage, anaemia

Abnormal placentation and the friability of molar-type tissue can increase the risk of bleeding during pregnancy and delivery. Case reports and series describe maternal anaemia and haemorrhagic complications in partial mole settings.⁹ Prompt recognition and appropriate obstetric planning (with blood availability) are therefore important.

Ovarian hyperstimulation-type reactions and other sequelae 

Rarely, large trophoblastic masses can cause ovarian theca-lutein cysts or systemic reactions resembling ovarian hyperstimulation syndrome (reported rarely after triploid conceptus evacuation).¹⁰ Multidisciplinary care is often required.

Management and obstetric care

Management depends on gestational age, maternal condition, and whether the pregnancy is viable and desired. Key principles include:¹¹

• Early recognition and multidisciplinary care: If triploidy or partial mole is suspected, prompt specialist referral (maternal-fetal medicine, obstetrics, gynaecologic oncology if GTD is suspected) is essential. Frequent monitoring of maternal blood pressure, urine protein, and haematologic markers is advised
• Surveillance for hypertensive disease and mirror syndrome: Given the risk of early severe preeclampsia, clinicians should maintain a low threshold for investigation and intervention; atypical preeclampsia before 20 weeks should trigger consideration of an abnormal placental process
• Definitive diagnosis and counselling: Cytogenetics of fetal or placental tissue confirms diagnosis and helps prognosticate (diandric vs digynic). Genetic counselling should cover recurrence risk (generally low for sporadic triploidy), implications for future pregnancies, and available reproductive options
• Evacuation when maternal risk outweighs continuation: If maternal health is threatened (severe preeclampsia, heavy bleeding, persistent high β-hCG), pregnancy termination or evacuation is usually recommended. After evacuation, serial β-hCG monitoring is needed to exclude persistent trophoblastic disease
• Psychosocial and reproductive support: Given the emotional impact of pregnancy loss or termination and concerns about recurrence, psychological support and specialist counselling (including genetic counselling) are integral to care

Prognosis for mother and future pregnancies 

For most women, the complications caused by triploidy resolve once the abnormal placental tissue is removed. Although persistent gestational trophoblastic disease is uncommon after a partial molar pregnancy, it must always be excluded through careful follow-up with serial β-hCG testing, which monitors for any remaining trophoblastic activity.

The risk of recurrence of triploidy is generally considered low, and most cases are thought to arise sporadically rather than being inherited. In rare situations, however, such as families with recurrent molar disease or where parental chromosomal abnormalities are suspected, genetic counselling and further investigation may be recommended.

Reassuringly, the outlook for future pregnancies is usually good. Most women go on to have normal outcomes with standard antenatal care. One important exception is for women who developed severe preeclampsia in their triploid pregnancy. These women carry a higher risk of long-term cardiovascular disease, meaning ongoing follow-up and preventive care are advisable to protect their health beyond pregnancy.

Counselling points for clinicians to communicate 

• Triploidy is usually sporadic and not typically inherited; recurrence is uncommon
• Troploidy is generally incompatible with life; the primary maternal concern is placental-related complications (preeclampsia, bleeding, rare persistent trophoblastic disease)
• Early diagnosis enables tailored monitoring and reduces the risk of severe maternal morbidity

FAQs

How common is triploidy? 

Triplodiy is common in live births but relatively common among very early pregnancy losses; estimates vary, but around 1-2% of conceptuses may be triploid, and many such pregnancies miscarry early. 

Can a triploid pregnancy be carried to term?

Very rarely. Most triploid conceptuses are lost in the first or early second trimester. A small number of mosaic or confined placental mosaicism cases may have different outcomes, but such live births are exceptional. 

Will triploidy affect future pregnancies?

In most cases, triploidy is sporadic, and the recurrence risk is low. Genetic counselling and, if indicated, parental karyotyping can clarify individual recurrence risks. 

Summary

Triploidy is a catastrophic chromosomal abnormality for fetal development, but it also carries important implications for maternal health when the placenta exhibits trophoblastic/molar changes. The highest maternal risks, early severe preeclampsia, mirror syndrome, haemorrhage, and, rarely, persistent trophoblastic disease, are principally associated with diandric (paternal excess) triploidy and partial molar placentae. Early identification, multidisciplinary care, close maternal surveillance, and appropriate post-evacuation follow-up are central to minimising maternal morbidity and ensuring optimal counselling for future pregnancies.